ANAL CARCINOMA
Clinical trials for ANAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ANAL CARCINOMA trials appear
Sign up with your email to follow new studies for ANAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer drug trial halted early
Disease control TerminatedThis early-phase study tested a new drug called INCB099318 in 105 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety and how the body processes it. The study was terminated early, so results are limit…
Matched conditions: ANAL CARCINOMA
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 17, 2026 03:16 UTC
-
Immunotherapy duo shows promise for HIV patients with tough cancers
Disease control TerminatedThis study tested a combination of two immunotherapy drugs, ipilimumab and nivolumab, in people with HIV who also had advanced solid tumors or Hodgkin lymphoma. The goal was to find the safest dose and see if the drugs could shrink tumors. The trial was stopped early, but it prov…
Matched conditions: ANAL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 03:14 UTC